Green Thumb Industries (GTBIF) Cash from Operations Growth (3y) (2022 - 2026)
Green Thumb Industries (GTBIF) Cash from Operations Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | 8.25% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 52.97% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 5.90% |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | 43.42% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -10.08% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | -8.76% |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | 65.60% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Green Thumb Industries | 1.65 Bn | 1.37 Bn | 137.87 Mn | 16.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.57% |
| Mar 31, 2026 | 0.48% |
| Dec 31, 2025 | 8.62% |
| Sep 30, 2025 | 15.34% |
| Jun 30, 2025 | 78.12% |
| Mar 31, 2025 | 10.25% |
| Dec 31, 2024 | -4.19% |
| Sep 30, 2024 | 11.41% |
| Jun 30, 2024 | 32.61% |
| Mar 31, 2024 | 28.44% |
| Dec 31, 2023 | 41.94% |
| Sep 30, 2023 | 77.90% |
| Jun 30, 2023 | -17.98% |
| Mar 31, 2023 | 40.31% |
| Dec 31, 2022 | 82.37% |
| Sep 30, 2022 | 126.42% |
| Jun 30, 2022 | -199.61% |
| Mar 31, 2022 | 145.96% |